The establishment of Innovation Gateway, a high-quality incubator space for life-science companies at The London Cancer Hub in Sutton, is underway.
This is a significant step in realising the aims of The London Cancer Hub, a partnership between the London Borough of Sutton and The Institute of Cancer Research, that is attempting to establish an internationally recognised district for cancer research, treatment and commercial enterprise.
The Innovation Gateway will offer companies the chance to work side by side with scientists at The Institute of Cancer Research (ICR) within mixed laboratory, office and collaboration space.
It is due to open in late 2021 and will be made up of companies related to cancer, with a particular emphasis on accommodating start-ups, spin-outs and small teams from the biotech, medtech, data science and pharmaceutical industries.
The building is being refurbished alongside a planned redevelopment of the surrounding space to create a public realm, which will join the Innovation Gateway with the adjacent Centre for Cancer Drug Discovery, a new science building at the ICR.
There are opportunities for companies at the Innovation Gateway to work directly with ICR researchers in a range of areas including drug discovery and development, immuno-oncology, Big Data and AI, microscopy, imaging and medical physics.
Professor Paul Workman, Chief Executive at The Institute of Cancer Research, London, said: “The ICR is a world leading academic centre for cancer drug discovery and we already collaborate with more than 100 companies to take new treatments to patients. This new development represents the first opportunity for companies to work directly with our scientists and clinicians from a base on site, and we are very excited about bringing in new tenants to further enhance our work in collaboration with industry to create new treatments for cancer patients.”